Mr. Walton spoke at MDMA’s annual meeting in late May and discussed his experiences as a patient undergoing spinal fusion surgery and the challenges the industry faces, including the medical device excise tax, regulatory struggles with the FDA and reimbursement with CMS. After his speech, Mr. Walton and NuVasive CEO Alex Lukianov traveled to Capitol Hill to lobby lawmakers on these issues.
Related Articles on Medical Devices:
Smith & Nephew Voluntarily Withdraws Hip System Component
Maine Plans Statewide Medical Image Archive Pilot
Amedica Names Brian McEntire Chief Technology Officer
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
